Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines

Ho C, Wright MD
Record ID 32011001222
Authors' recommendations: Evidence on the effectiveness and feasibility of universal development assessment tools in 18 month old children is very limited. The literature suggests that CAT/CLAMS may be useful as a developmental assessment tool for preterm children at 18 months of age. While ASQ and CDH were found to have low sensitivity and specificity, TBCS and CHAT may be valid as screening tools at 18 months of age. The literature also indicates that children 18 months of age may be an optimal age to assess cognitive-adaptive delay in preterm infants using CAT/CLAMS. Additional research is needed to develop a screening protocol that will enhance the capability for earlier detection of children with developmental delays.
Project Status: Completed
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Infant
  • Neurologic Examination
  • Physical Examination
  • Predictive Value of Tests
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.